So far, markers for methylated human genes with prognostic relevance in blood-based testing include CADM1, DAPK and CDH1. Especially for CADM1, multiple studies have been published showing that this marker can differentiate between benign and malignant cervical disease and may function as a tumour metastasis marker in blood [57]. Here, CADM1 is linked to neoplasm.